CTHRC1 is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer

Cancer Science

Volumn 103, Issue 7, 2012, Pages 1327-1333

  Wang, Ping ^a,b   Wang, Ying Chao ^a   Chen, Xiao Yu ^a   Shen, Zhi Yong ^a   Cao, Hui ^a   Zhang, Yan Jie ^a   Yu, Jian ^c   Zhu, Jing De ^c   Lu, You Yong ^d   Fang, Jing Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c SHANGHAI CANCER INSTITUTE   (China)

^d PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; ATROPHIC GASTRITIS; CANCER CELL CULTURE; CANCER INVASION; CHRONIC GASTRITIS; CONTROLLED STUDY; DEMETHYLATION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA INTERFERENCE; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA; UPREGULATION;

APOPTOSIS; AZACITIDINE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DNA METHYLATION; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; METAPLASIA; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84863326886     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02292.x     Document Type: Article

References (30)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-62.
2. Vogiatzi P, Vindigni C, Roviello F, Renieri A, Giordano A. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J Cell Physiol 2007; 211: 287-95.
3. Jankowski JA, Odze RD. Biomarkers in gastroenterology: between hope and hype comes histopathology. Am J Gastroenterol 2009; 104: 1093-6.
4. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell, 2006; 127: 679-95.
5. Steven CS, Dan T N. Learning therapeutic lessons from metastasis suppressor proteins. Rev Cancer 2009; 9: 253-64.
6. Tie J, Pan Y, Zhao L et al. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 2010; 6: e1000879.
7. Pyagay P, Heroult M, Wang Q et al. Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circ Res 2005; 96: 261-8.
8. Tang L, Dai DL, Su M, Martinka M, Li G, Zhou Y. Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Clin Cancer Res, 2006; 12: 3716-22.
9. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
10. Chinese Society of Gastroenterology. Consensus on chronic gastritis in China. Chin J Gastroenterol 2006; 11: 674-84.
11. Rugge M, Correa P, Dixon MF et al. Gastric dysplasia, the Padova international classification. Am J Surg Pathol 2000; 24: 167-76.
12. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-8.
13. Jun HJ, Woolfenden S, Coven S et al. Epigenetic regulation of c-ROS receptor tyrosine kinase expression in malignant gliomas. Cancer Res 2009; 69: 2180-4.
14. Lu R, Wang X, Chen ZF, Sun DF, Tian XQ, Fang JY. Inhibition of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway decreases DNA methylation in colon cancer cells. J Biol Chem 2007; 282: 12249-59.
15. Hecht M, Papoutsi M, Tran HD, Wilting J, Schweigerer L. Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas. Cancer Res 2004; 64: 6109-18.
16. Wang YY, Zhou GB, Yin T et al. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia, implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci USA 2005; 102: 1104-9.
17. Leclair RJ, Wang Q, Benson MA, Prudovsky I, Lindner V. Intracellular localization of Cthrc1 characterizes differentiated smooth muscle. Arterioscler Thromb Vasc Biol 2008; 28: 1332-8.
18. LeClair RJ, Lindner V. The role of collagen triple helix repeat containing 1 in injured arteries, collagen expression, and transforming growth factor beta signaling. Trends Cardiovasc Med 2007; 17: 202-5.
19. Turashvili G, Bouchal J, Baumforth K et al. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 2007; 7: 55.
20. Fang JY, Xiao SD. Alteration of DNA methylation in gastrointestinal carcinogenesis. J Gastroenterol Hepatol 2001; 16: 960-8.
21. Dehan P, Kustermans G, Guenin S, Horion J, Boniver J, Delvenne P. DNA methylation and cancer diagnosis: new methods and applications. Expert Rev Mol Diagn 2009; 9: 651-7.
22. Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 2011; 11: 726-34.
23. Swami M. Epigenetics: demethylation links cell fate and cancer. Nat Rev Cancer 2010; 10: 740.
24. Wild L, Flanagan JM. Genome-wide hypomethylation in cancer may be a passive consequence of transformation. Biochim Biophys Acta 2010; 1806: 50-7.
25. Oft M, Heider KH, Beug H. TGF-β signaling is necessary for carcinoma cell invasiveness andmetastasis. CurrBiol 1998; 8: 1243-52.
26. Leivonen SK, VeliMatti K. Transforming growth factor-β signaling in cancer invasion and metastasis. Int J Cancer 2007; 121: 2119-24.
27. Perera M, Tsang CS, Distel RJ et al. TGF-beta1 interactome: metastasis and beyond. Cancer Genomics Proteomics 2010; 7: 217-29.
28. Hawinkels LJ, Verspaget HW, van Duijn W et al. Tissue level, activation and cellular localisation of TGF-β1 and association with survival in gastric cancer patients. Br J Cancer 2007; 97: 398-404.
29. Wu WK, Cho CH, Lee CW et al. Dysregulation of cellular signaling in gastric cancer. Cancer Lett 2010; 295: 144-53.
30. LeClair RJ, Durmus T, Wang Q, Pyagay P, Terzic A, Lindner V. Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation. Circ Res 2007; 100: 826-33.